Lawmakers in Maryland are daring to legislate where theirfederal counterparts have not: As of Oct. 1, the state will be ableto say “no” to some pharmaceutical price spikes.
A new law, which focuses on generic and off-patent drugs,empowers the state’s attorney general to step in if a drug’s priceclimbs 50 percent or more in a single year. Thecompany must justify the hike. If the attorney general stillfinds the increase unwarranted, he or she can file suit in statecourt. Manufacturers face a fine of up to $10,000 for pricegouging.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
